178 related articles for article (PubMed ID: 25712625)
1. Synchronous gastric and ampullary adenocarcinomas in a hairy cell leukemia patient treated with pentostatin eight years prior.
Senatore FJ; Dasanu CA
J Oncol Pharm Pract; 2016 Jun; 22(3):543-7. PubMed ID: 25712625
[TBL] [Abstract][Full Text] [Related]
2. Long-term follow-up of remission duration, mortality, and second malignancies in hairy cell leukemia patients treated with pentostatin.
Flinn IW; Kopecky KJ; Foucar MK; Head D; Bennett JM; Hutchison R; Corbett W; Cassileth P; Habermann T; Golomb H; Rai K; Eisenhauer E; Appelbaum F; Cheson B; Grever MR
Blood; 2000 Nov; 96(9):2981-6. PubMed ID: 11049974
[TBL] [Abstract][Full Text] [Related]
3. Pentostatin (Nipent) in T-cell malignancies. Leukemia Cooperative Group and the European Organization for Research and Treatment of Cancer.
Ho AD; Suciu S; Stryckmans P; De Cataldo F; Willemze R; Thaler J; Peetermans M; Döhner H; Solbu G; Dardenne M; Zittoun R
Semin Oncol; 2000 Apr; 27(2 Suppl 5):52-7. PubMed ID: 10877053
[TBL] [Abstract][Full Text] [Related]
4. Long-term outcome following treatment of hairy cell leukemia with pentostatin (Nipent): a National Cancer Institute of Canada study.
Johnston JB; Eisenhauer E; Wainman N; Corbett WE; Zaentz SD; Daeninck PJ
Semin Oncol; 2000 Apr; 27(2 Suppl 5):32-6. PubMed ID: 10877049
[TBL] [Abstract][Full Text] [Related]
5. Long-term outcome with pentostatin treatment in hairy cell leukemia patients. A French retrospective study of 238 patients.
Maloisel F; Benboubker L; Gardembas M; Coiffier B; Divine M; Sebban C; Blanc M; Abgrall JF; Lederlin P; Harousseau JL; Blaise AM; Grosbois B; Morice P; Ghandour C; Castaigne S
Leukemia; 2003 Jan; 17(1):45-51. PubMed ID: 12529659
[TBL] [Abstract][Full Text] [Related]
6. Long term outcome of patients with hairy cell leukemia treated with pentostatin.
Ribeiro P; Bouaffia F; Peaud PY; Blanc M; Salles B; Salles G; Coiffier B
Cancer; 1999 Jan; 85(1):65-71. PubMed ID: 9921975
[TBL] [Abstract][Full Text] [Related]
7. Myelodysplasia terminating in acute myeloid leukemia in a hairy cell leukemia patient treated with 2-deoxycoformycin.
Todd SA; Morris TC; Alexander HD
Leuk Lymphoma; 2002 Jun; 43(6):1343-4. PubMed ID: 12153007
[TBL] [Abstract][Full Text] [Related]
8. Development of essential thrombocythemia in a patient treated with interferon alfa and pentostatin for hairy cell leukemia.
Lichtman SM; Wasil T; Ahmad M; Brody J
Leuk Lymphoma; 1998 Jan; 28(3-4):423-7. PubMed ID: 9517515
[TBL] [Abstract][Full Text] [Related]
9. Persistent bone marrow failure with dysplastic features following pentostatin therapy for hairy cell leukaemia.
Psiachou-Leonard E; Bain BJ
Clin Lab Haematol; 1998 Jun; 20(3):195-7. PubMed ID: 9681239
[TBL] [Abstract][Full Text] [Related]
10. Epithelioid microgranulomas after Pentostatin therapy in hairy cell leukaemia.
Sironi M; Lodato A; Sciariada L; Spinelli M
Histopathology; 2002 May; 40(5):483-5. PubMed ID: 12010371
[No Abstract] [Full Text] [Related]
11. Hairy-cell leukaemia: first-line treatment with cladribine or pentostatin.
Prescrire Int; 2006 Aug; 15(84):143-4. PubMed ID: 16989031
[TBL] [Abstract][Full Text] [Related]
12. Pentostatin-induced hypereosinophilia with eosinophilic gastroenteritis.
Shouval R; Duffield A; Gocke C; Lee L; Brodsky RA
Leuk Lymphoma; 2010 Aug; 51(8):1567-9. PubMed ID: 20496999
[No Abstract] [Full Text] [Related]
13. Phase II trials of pentostatin (Nipent) in hairy cell leukemia.
Kraut EH
Semin Oncol; 2000 Apr; 27(2 Suppl 5):27-31. PubMed ID: 10877048
[TBL] [Abstract][Full Text] [Related]
14. Clinical overview of pentostatin (Nipent) use in lymphoid malignancies.
Dearden CE; Matutes E; Catovsky D
Semin Oncol; 2000 Apr; 27(2 Suppl 5):22-6. PubMed ID: 10877047
[TBL] [Abstract][Full Text] [Related]
15. Successful treatment of a patient with hairy cell leukemia and pentostatin-induced autoimmune thrombocytopenia with rituximab.
Hensel M; Ho AD
Am J Hematol; 2003 May; 73(1):37-40. PubMed ID: 12701118
[TBL] [Abstract][Full Text] [Related]
16. Risk of additional cancers in untreated and treated hairy cell leukemia patients.
Dasanu CA; Alexandrescu DT
Expert Opin Pharmacother; 2010 Jan; 11(1):41-50. PubMed ID: 20001428
[TBL] [Abstract][Full Text] [Related]
17. Successful treatment of extranodal Hodgkin's lymphoma in a patient with longstanding hairy cell leukemia.
Gotic M; Cemerikic V; Elezovic I; Boskovic D; Bila J; Magic Z; Jocic DJ; Pavlovic D; Grujicic D; Stosic T; Wotherspoon A; Catovsky D
Leuk Lymphoma; 2005 May; 46(5):765-9. PubMed ID: 16019516
[TBL] [Abstract][Full Text] [Related]
18. [Successful treatment of hairy cell leukemia with pentostatin].
Fujita H; Koharazawa H; Nishida H; Terada S; Morishita T; Kuroyama Y; Ohata M; Ishigatsubo Y
Rinsho Ketsueki; 2001 Jul; 42(7):537-42. PubMed ID: 11524843
[TBL] [Abstract][Full Text] [Related]
19. Pentostatin induces durable remissions in hairy cell leukemia.
Cassileth PA; Cheuvart B; Spiers AS; Harrington DP; Cummings FJ; Neiman RS; Bennett JM; O'Connell MJ
J Clin Oncol; 1991 Feb; 9(2):243-6. PubMed ID: 1988572
[TBL] [Abstract][Full Text] [Related]
20. Weekly intermittent 2-CdA is less toxic and equally efficacious when compared to continuous infusion in hairy cell leukaemia.
Chacko J; Murphy C; Duggan C; O'Briain DS; Browne PV; McCann SR
Br J Haematol; 1999 Jun; 105(4):1145-6. PubMed ID: 10554836
[No Abstract] [Full Text] [Related]
[Next] [New Search]
